These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 2055721)

  • 41. Brain imaging in functional mental disorders.
    Young T; Williamson P
    Can J Psychiatry; 1986 Oct; 31(7):675-80. PubMed ID: 3490900
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Positron emission tomography studies of abnormal glucose metabolism in schizophrenia.
    Buchsbaum MS; Hazlett EA
    Schizophr Bull; 1998; 24(3):343-64. PubMed ID: 9718628
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Positron emission tomography studies of abnormal glucose metabolism in schizophrenic illness.
    Buchsbaum MS
    Clin Neurosci; 1995; 3(2):122-30. PubMed ID: 7583618
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The study of panic disorder using positron emission tomography.
    Reiman EM
    Psychiatr Dev; 1987; 5(1):63-78. PubMed ID: 3496592
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Regional cerebral metabolism associated with anxiety symptoms in affective disorder patients.
    Osuch EA; Ketter TA; Kimbrell TA; George MS; Benson BE; Willis MW; Herscovitch P; Post RM
    Biol Psychiatry; 2000 Nov; 48(10):1020-3. PubMed ID: 11082477
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Functional neuroimaging in psychiatry.
    Fu CH; McGuire PK
    Philos Trans R Soc Lond B Biol Sci; 1999 Jul; 354(1387):1359-70. PubMed ID: 10466156
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Regional neural dysfunctions in chronic schizophrenia studied with positron emission tomography.
    Kim JJ; Mohamed S; Andreasen NC; O'Leary DS; Watkins GL; Boles Ponto LL; Hichwa RD
    Am J Psychiatry; 2000 Apr; 157(4):542-8. PubMed ID: 10739412
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Molecular imaging of psychiatric disorders].
    Takahashi H; Suhara T
    Nihon Rinsho; 2007 Feb; 65(2):336-41. PubMed ID: 17302281
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Thyroid, brain and mood modulation in affective disorder: insights from molecular research and functional brain imaging.
    Bauer M; London ED; Silverman DH; Rasgon N; Kirchheiner J; Whybrow PC
    Pharmacopsychiatry; 2003 Nov; 36 Suppl 3():S215-21. PubMed ID: 14677082
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Mood disorders.
    Yurgelun-Todd DA; Sava S; Dahlgren MK
    Neuroimaging Clin N Am; 2007 Nov; 17(4):511-21, ix. PubMed ID: 17983967
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Emotion regulation in mood and anxiety disorders: A meta-analysis of fMRI cognitive reappraisal studies.
    Picó-Pérez M; Radua J; Steward T; Menchón JM; Soriano-Mas C
    Prog Neuropsychopharmacol Biol Psychiatry; 2017 Oct; 79(Pt B):96-104. PubMed ID: 28579400
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Neuroimaging in pursuit of neurobiology: strengths, limitations, and the quest for new paradigms in depression and mood.
    Kumar A
    Am J Geriatr Psychiatry; 2000; 8(4):284-8. PubMed ID: 11069267
    [No Abstract]   [Full Text] [Related]  

  • 53. Psychosis and positron tomography.
    Seeman MV; Seeman P
    Can J Psychiatry; 1988 May; 33(4):299-306. PubMed ID: 3289723
    [TBL] [Abstract][Full Text] [Related]  

  • 54. PET study of D(1) dopamine receptor binding in neuroleptic-naive patients with schizophrenia.
    Karlsson P; Farde L; Halldin C; Sedvall G
    Am J Psychiatry; 2002 May; 159(5):761-7. PubMed ID: 11986129
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Structural and functional cerebral changes in patients with schizophrenia].
    Rubin PJ; Hemmingsen RP
    Ugeskr Laeger; 1993 Jan; 155(1):16-21. PubMed ID: 8421841
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Use of positron emission tomography for the evaluation of epilepsy.
    DeCarli C; McIntosh AR; Blaxton TA
    Neuroimaging Clin N Am; 1995 Nov; 5(4):623-45. PubMed ID: 8564287
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Positron emission tomography--examination of chemical transmission in the living human brain. Development of radioligands.
    Farde L; Hall H
    Arzneimittelforschung; 1992 Feb; 42(2A):260-4. PubMed ID: 1316756
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Spatial low frequency pattern analysis in positron emission tomography: a study between normals and schizophrenics.
    Levy AV; Gomez-Mont F; Volkow ND; Corona JF; Brodie JD; Cancro R
    J Nucl Med; 1992 Feb; 33(2):287-95. PubMed ID: 1732457
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Neurotransmitters are important, but so is metabolism. Commentary on "The current status of PET scanning with respect to schizophrenia".
    Gur RE; Gur RC
    Neuropsychopharmacology; 1992 Aug; 7(1):63-5; discussion 73-5. PubMed ID: 1355969
    [No Abstract]   [Full Text] [Related]  

  • 60. Informed consent and neuroanatomic correlates of intentionality and voluntariness among psychiatric patients.
    Grimes AL; McCullough LB; Kunik ME; Molinari V; Workman RH
    Psychiatr Serv; 2000 Dec; 51(12):1561-7. PubMed ID: 11097654
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.